Gregory L. Shiferman - 06 Jan 2026 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Reporting relationship: SVP and General Counsel
Issuer ticker: VYGR
Reported as of: 06 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jan 2026, 18:10:46 UTC
Prior SEC filing: 31 Jul 2025
Next SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Gregory L. Shiferman

Key filing fact

Gregory L. Shiferman filed Form 4 for Voyager Therapeutics, Inc. (VYGR) on 08 Jan 2026.

Key facts

This page summarizes Gregory L. Shiferman's Form 4 filing for Voyager Therapeutics, Inc. (VYGR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jan 2026, 18:10.

Change

Previous filing in this sequence was filed on 31 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002041689 Primary reporting owner

Shiferman Gregory L.

Relationship: SVP and General Counsel
Address: C/O VOYAGER THERAPEUTICS, INC., 75 HAYDEN AVENUE, LEXINGTON
Signature: /s/ Gregory L. Shiferman
Signature date: 08 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VYGR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 06 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $4.02
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This stock option was granted pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan.

Footnote F2

The vesting commencement date of the option is the grant date. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee.